A series of proteins with increased expression in BC, including γ-catenin, PDK1, tyrosine protein kinase receptor A (TrkA), and Ephrin type-A receptor 2 (EphA2), positively regulate the PI3K-AKT pathway and impair anoikis function in BC [176]. The gene discussed is NTRK1; the disease is breast cancer.